Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
Actual shortage: | 240 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
27 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT EXEMESTANE | 25MG | TABLET | Resolved | 2022-09-22 | 2023-01-19 | 170011 |
AVIANE 21 | 20MCG 100MCG | TABLET | Resolved | 2022-09-30 | 2022-12-02 | 170770 |
TEVA-CYCLOBENZAPRINE | 10MG | TABLET | Resolved | 2022-09-30 | 2023-01-19 | 170773 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2022-09-30 | 2022-12-08 | 170779 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2022-09-30 | 2022-12-15 | 170784 |
TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2022-09-30 | 2022-12-22 | 170792 |
TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2022-09-30 | 2022-12-15 | 170795 |
TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2022-09-30 | 2022-12-02 | 170798 |
TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2022-10-17 | 2023-01-12 | 172013 |
TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2022-10-17 | 2023-07-12 | 172018 |
TEVA-AZATHIOPRINE | 50MG | TABLET | Resolved | 2022-10-28 | 2022-12-08 | 173010 |
TEVA-SUMATRIPTAN DF | 25MG | TABLET | Resolved | 2022-10-28 | 2022-11-12 | 173028 |
TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2022-10-28 | 2022-12-15 | 173031 |
ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2022-10-28 | 2023-06-09 | 173040 |
TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2022-10-28 | 2023-06-09 | 173049 |
TEVA-PROPRANOLOL | 20MG | TABLET | Resolved | 2022-10-28 | 2023-01-11 | 173055 |
TEVA-EVEROLIMUS | 2.5MG | TABLET | Resolved | 2022-10-28 | 2022-12-08 | 173058 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-10-28 | 2023-01-12 | 173061 |
APRI 28 | 0.03MG 0.15MG | TABLET | Resolved | 2022-10-28 | 2022-12-02 | 173064 |
APRI 21 | 0.03MG 0.15MG | TABLET | Resolved | 2022-10-28 | 2022-12-02 | 173067 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |